For Consults please contact the MSBI Infectious Diseases Consult group on EPIC secure chat or the fellow listed on call on AMION
Fellows long distance pager prefix 14620 + pager number.
Administration / Escalation
1 - David Perlman MD, Chief, Infectious Diseases Cell: 917-282-5804
2 - Stanley Yancovitz MD, Fellowship Program Site Director Cell: 917-655-4552
3 - MSBI Hospital Director of Nursing: 212-420-3910
4 - MSBI Hospital Administrator on Duty: 212-420-3900
Infection Prevention
On weekdays, contact the Infection Prevention Department at 212-420-2853. On evenings, nights and weekends, please call the Nursing Supervisor for any bed management/infection prevention issues.
The Nursing Supervisor can reach Infection Prevention On Call at 646-799-6024.
Infection Control Policy #009, Care of the Patient with Communicable Diseases in the Inpatient and Outpatient Setting
Candida auris** active infection or prior history Special Contact Precautions Clostridium difficile, Sapovirus, Norovirus** active infection Special Contact Precautions CRE, MDR Pseudomonas, MDR Acinetobacter baumannii or any other significant MDR gram negative bacilli ** active infection or prior history within 1 year Contact Precautions ESBL all sites, active infection or prior history No precautions MRSA** active MRSA infection or 1 year history of MRSA in current open wound Contact Precautions MRSA nasal screen (+) or prior history of nasal MRSA No precautions VISA/VRSA/HVISA** active infection or prior history Contact Precautions VRE** No precautions unless resistant to Linezolid and/or Daptomycin, solid organ or hematopoietic stem cell transplant within the last 12 months or NICU patient
Candida auris**
active infection or prior history
Special Contact Precautions
Clostridium difficile, Sapovirus, Norovirus**
active infection
CRE, MDR Pseudomonas, MDR Acinetobacter baumannii or any other significant MDR gram negative bacilli **
active infection or prior history within 1 year
Contact Precautions
ESBL
all sites, active infection or prior history
No precautions
MRSA**
active MRSA infection or 1 year history of MRSA in current open wound
MRSA
nasal screen (+) or prior history of nasal MRSA
VISA/VRSA/HVISA**
VRE**
No precautions unless resistant to Linezolid and/or Daptomycin, solid organ or hematopoietic stem cell transplant within the last 12 months or NICU patient
**Patients may only be cohorted with a roommate who has the same organism (e.g. CRE+CRE; MDR Acinetobacter + MDR Acinetobacter; MRSA + MRSA)